Hakan Erdogan, F. Pehlivanoğlu, G. Şengöz, Feride Velaei̇
{"title":"Evaluation of Antibody Levels After Vaccination (Sinovac-CoronaVac) in Healthcare Workers","authors":"Hakan Erdogan, F. Pehlivanoğlu, G. Şengöz, Feride Velaei̇","doi":"10.5799/jmid.1218640","DOIUrl":null,"url":null,"abstract":"Objectives: This study aims to evaluate the effectiveness of the inactivated SARS-COV-2 vaccine (Sinovac-CoronaVac), first administered to healthcare professionals in Turkey on January 14, 2021. \nMethods: Healthcare professionals without a history of COVID-19, PCR test positivity, or chronic disease were included in the study. The antibody levels for S1 RBD antigen were measured with the Siemens SARS-CoV-2 IgG (sCOVG) kit one month and six months after the two-dose CoronaVac vaccine. \nResults: A total of 108 health professionals, 35 women and 73 men, were included in this study. The mean age of the participants was 37.5 ± 10.7 years. A total of 103 (95.3%) individuals had positive antibody values, and five (4.6%) had negative values after the second vaccination. After the second vaccine dose, 11 (10.1%) participants were diagnosed with COVID-19. There was a significant decrease in antibody values in the sixth month compared to the first month (p","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Microbiology and Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5799/jmid.1218640","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objectives: This study aims to evaluate the effectiveness of the inactivated SARS-COV-2 vaccine (Sinovac-CoronaVac), first administered to healthcare professionals in Turkey on January 14, 2021.
Methods: Healthcare professionals without a history of COVID-19, PCR test positivity, or chronic disease were included in the study. The antibody levels for S1 RBD antigen were measured with the Siemens SARS-CoV-2 IgG (sCOVG) kit one month and six months after the two-dose CoronaVac vaccine.
Results: A total of 108 health professionals, 35 women and 73 men, were included in this study. The mean age of the participants was 37.5 ± 10.7 years. A total of 103 (95.3%) individuals had positive antibody values, and five (4.6%) had negative values after the second vaccination. After the second vaccine dose, 11 (10.1%) participants were diagnosed with COVID-19. There was a significant decrease in antibody values in the sixth month compared to the first month (p